Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wai Han Yiu

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 3, 2018
Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathyWai Han Yiu, Rui Xi Li, Dickson W L Wong, et al.
Plos One|March 21, 2014
Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosisHao Jia Wu, Wai Han Yiu, Rui Xi Li, et al.
Kidney International|April 2, 2018
Activated renal tubular Wnt/β-catenin signaling triggers renal inflammation during overload proteinuriaDickson W L Wong, Wai Han Yiu, Kam Wa Chan, et al.
Clinical Science (London, England : 1979)|January 18, 2021
Protective role of kallistatin in renal fibrosis via modulation of Wnt/β-catenin signalingWai Han Yiu, Ye Li, Sarah W Y Lok, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 12, 2023
Add-on Rehmannia-6-Based Chinese Medicine in Type 2 Diabetes and CKD: A Multicenter Randomized Controlled TrialKam Wa Chan, Alfred Siu Kei Kwong, Kathryn Choon Beng Tan, et al.
BMJ Open|January 13, 2021
Efficacy, safety and response predictors of adjuvant astragalus for diabetic kidney disease (READY): study protocol of an add-on, assessor-blind, parallel, pragmatic randomised controlled trialKam Wa Chan, Alfred Siu Kei Kwong, Pun Nang Tsui, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 29, 2024
Add-on astragalus in type 2 diabetes and chronic kidney disease: A multi-center, assessor-blind, randomized controlled trialKam Wa Chan, Alfred Siu Kei Kwong, Pun Nang Tsui, et al.
BMC Complementary Medicine and Therapies|July 4, 2020
Patients' and clinicians' expectations on integrative medicine Services for Diabetes: a focus group studyKam Wa Chan, Pak Wing Lee, Crystal Pui Sha Leung, et al.
BMJ Open|August 7, 2016
Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trialKam Wa Chan, Tai Pang Ip, Alfred Siu Kei Kwong, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 3, 2018
Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathyWai Han Yiu, Rui Xi Li, Dickson W L Wong, et al.
Plos One|March 21, 2014
Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosisHao Jia Wu, Wai Han Yiu, Rui Xi Li, et al.
Kidney International|April 2, 2018
Activated renal tubular Wnt/β-catenin signaling triggers renal inflammation during overload proteinuriaDickson W L Wong, Wai Han Yiu, Kam Wa Chan, et al.
Clinical Science (London, England : 1979)|January 18, 2021
Protective role of kallistatin in renal fibrosis via modulation of Wnt/β-catenin signalingWai Han Yiu, Ye Li, Sarah W Y Lok, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 12, 2023
Add-on Rehmannia-6-Based Chinese Medicine in Type 2 Diabetes and CKD: A Multicenter Randomized Controlled TrialKam Wa Chan, Alfred Siu Kei Kwong, Kathryn Choon Beng Tan, et al.
BMJ Open|January 13, 2021
Efficacy, safety and response predictors of adjuvant astragalus for diabetic kidney disease (READY): study protocol of an add-on, assessor-blind, parallel, pragmatic randomised controlled trialKam Wa Chan, Alfred Siu Kei Kwong, Pun Nang Tsui, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 29, 2024
Add-on astragalus in type 2 diabetes and chronic kidney disease: A multi-center, assessor-blind, randomized controlled trialKam Wa Chan, Alfred Siu Kei Kwong, Pun Nang Tsui, et al.
BMC Complementary Medicine and Therapies|July 4, 2020
Patients' and clinicians' expectations on integrative medicine Services for Diabetes: a focus group studyKam Wa Chan, Pak Wing Lee, Crystal Pui Sha Leung, et al.
BMJ Open|August 7, 2016
Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trialKam Wa Chan, Tai Pang Ip, Alfred Siu Kei Kwong, et al.
Pageof 5